HONG KONG – Founded only last year, Boston-Shanghai clinical-stage biotech startup Anji Pharmaceuticals Inc. is using its team's ties to big pharma to bring in valuable assets to be developed for indications suffered by Chinese patients, especially metabolic diseases. Most recently, it in-licensed Novartis AG's pradigastat, an inhibitor of acyl coA: diacylglycerol acyl transferase, or DGAT1, which has progressed to phase III testing in familial chylomicronemia syndrome (FCS). Read More
Biopharma licensing deals signed in 2018 climbed to 1,364 and have a projected value of $119.54 billion, a four-year high for an industry still riding the immuno-oncology wave. Read More
HONG KONG – The Indian Ministry of Chemicals and Fertilizers has exempted foreign makers of new drugs patented under India's Patents Act 1970 (39 of 1970) from price regulation for five years. Read More
NEW DELHI, India – Princeton, N.J.-based Vyome Therapeutics Inc., which specializes in medicines for treating skin diseases caused by resistant microbes, has announced a $22 million financing for the phase IIb trial of its lead molecule, VB-1953, for treatment of moderate to severe acne. Read More
It's been 30 or so years since amyloid beta precursor protein (APP) was first pinpointed as the precursor of the amyloid beta (AB) peptide that is the main constituent of plaques found in the brains of Alzheimer's disease (AD) patients. Read More
PERTH, Australia – Like many Aussie companies, Invion Ltd. started out with some assets that it had a difficult time progressing forward, and it ended up remaking itself into a completely different company with new assets. Now, Melbourne-headquartered Invion plans to enter the clinic early this year with a photosensitizer therapy to treat melanoma. Read More
Olix Pharmaceuticals Inc., of Suwon, South Korea, said it nominated OLX-10020 as a clinical candidate for geographic atrophy (GA), a severe and advanced form of dry age-related macular degeneration (AMD). OLX-10020 is designed to target an undruggable gene involved in GA, identified by Jayakrishna Ambati, a professor at the University of Virginia, School of Medicine. Read More
